Cytokine Receptor Common β Chain as a Potential Activator of Cytokine Withdrawal-Induced Apoptosis

Abstract

Growth factors and cytokines play an important role in supporting cellular viability of various tissues during development due to their ability to suppress the default cell death program in each cell type. To date, neither the triggering molecule nor the transduction pathway of these default apoptosis programs is understood. In this study, we explored the possibility that cytokine receptors are involved in modulating cytokine withdrawal-induced apoptosis (CWIA) in hematopoietic cells. Expression of the exogenous cytokine receptor common β chain (βc), but not the α chains, accelerated CWIA in multiple cytokine-dependent cell lines. Reduction of the expression level of endogenous βc by antisense transcripts resulted in prolonged survival during cytokine deprivation, suggesting a critical role of βc in modulating CWIA. Fine mapping of the βc subunit revealed that a membrane-proximal cytoplasmic sequence, designated the death enhancement region (DER), was critical to the death acceleration effect of βc. Furthermore, DER accelerated cell death either as a chimeric membrane protein or as a cytosolic protein, suggesting that DER functions independently of the cytokine receptor and membrane anchorage. Cross-linking of the chimeric membrane-bound DER molecules by antibody or of the FK506-binding protein–DER fusion protein by a synthetic dimerizing agent, AP1510, did not abrogate the death acceleration effect. Transient transfection assays further indicated that DER promoted cell death in the absence of serum in the nonhematopoietic 293 cell line. In summary, our data suggest that βc plays an important role in modulating CWIA via an anchorage-independent and aggregation-insensitive mechanism. These findings may facilitate further studies on the signaling pathways of CWIA.

ACKNOWLEDGMENTS

We thank Young-Sun Lin, Yu-Chung Yang, and Atsushi Miyajima for critical comments on the manuscript, David Baltimore for the BOSC23 packaging cell line, Hartmut Land for retroviral expression vectors, and Ariad Pharmaceuticals for plasmid pCF1E and the synthetic dimerizing agent AP1510. We are also grateful to Derek W. Gilroy for preparation of the manuscript.

This work was supported in part by Academia Sinica, Taiwan (J.J.-Y.Y.) and the National Science Council of Taiwan (J.J.-Y.Y.). S.-F.L. was supported by a postdoctoral fellowship from Academia Sinica, Taiwan. H.-M.H. and J.-R.C. were supported by the postdoctoral fellowships of the National Science Council of Taiwan.